FDA Blocks OxyContin Generics, Citing Abuse Risks

By Rachel Slajda (April 16, 2013, 6:07 PM EDT) -- The Food and Drug Administration will not accept any applications to make a generic version of the popular painkiller OxyContin in its original, more easily abused form, which is due to come off patent this week, after the agency determined that the original OxyContin was pulled for safety reasons, it said Tuesday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!